99% COA-Verified Purity | 6× Independent Testing | Batch-Level COAs | USA Based
This compound is part of our Research Peptides category and is supplied for use in controlled laboratory and in vitro research environments.
For laboratory research use only. Not for human or veterinary use.
$29.99 – $325.99Price range: $29.99 through $325.99
In stock
GHK-Cu peptide (Copper Tripeptide-1) is a naturally occurring copper-binding peptide composed of the amino acid sequence glycyl-L-histidyl-L-lysine complexed with copper (II), supplied for controlled laboratory and in vitro research environments. Current ghk-cu peptide research focuses on extracellular matrix-associated signaling pathways, angiogenesis-related molecular mechanisms, and cellular response processes at the molecular level.
In laboratory settings, ghk-cu peptide is studied for its role in copper-dependent peptide interactions, gene-expression signaling, and tissue-associated molecular pathways under controlled experimental conditions. Researchers evaluate how copper-binding peptides influence signaling coordination, cellular communication, and pathway dynamics.
GHK-Cu peptide is frequently referenced in research literature examining peptide-based signaling interactions, extracellular matrix pathways, and copper-associated molecular systems under controlled laboratory conditions.
Current investigations continue to assess how peptide-based compounds interact within multi-pathway signaling environments, including potential influences on coordinated cellular processes and system-level biological responses in controlled laboratory models.
Research efforts are also focused on understanding how variations in experimental design, concentration, and molecular stability may affect peptide behavior across different in vitro systems and analytical frameworks.
Additional scientific literature on ghk-cu peptide and copper-associated signaling pathways can be explored through publicly available databases such as
PubMed.
Store at −20 °C (−4 °F) or below. Store in the original vial, sealed and protected from light and moisture until use. Avoid repeated freeze-thaw cycles.
GHK-Cu peptide is frequently studied alongside multi-component peptide blends and complementary compounds in laboratory research environments. Related compounds may include KLOW-80 peptide blend and GLOW-70 peptide blend.
This compound is part of our Peptides research category, which includes a range of laboratory-grade peptide compounds studied in controlled environments.
GHK-Cu peptide continues to be studied in research settings focused on extracellular matrix signaling pathways, copper-dependent peptide interactions, and coordinated molecular response systems under controlled laboratory conditions.
GHK-Cu peptide is studied in laboratory environments for its interaction with copper-dependent signaling pathways, extracellular matrix-associated systems, and angiogenesis-related molecular mechanisms.
This product is supplied as a lyophilized powder for controlled laboratory research use.
No. This product is strictly for research use only and is not intended for human or veterinary use.
All content and information provided are for educational and research reference purposes only. This product and its associated data have not been evaluated by the U.S. Food and Drug Administration, and no claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. No representations or warranties are made regarding safety, effectiveness, or outcomes.
This product is intended strictly for in vitro laboratory research use only and is not for clinical use. It is not approved for human or animal administration and must not be used in food, dietary supplements, pharmaceuticals, cosmetics, or any consumer applications.
By purchasing from Badger Compounds, the buyer affirms that they are a qualified researcher or institution with the appropriate training and facilities to handle research compounds in compliance with all applicable laws and regulations. All sales are final.